The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies

Bibliographic Details
Main Authors: White, Greg, Lee, Alina, Yuningsih, Yuni, Nielsen, C., Bukh, P.
Format: Journal Article
Published: Emerald 2010
Online Access:http://hdl.handle.net/20.500.11937/5518
_version_ 1848744819583614976
author White, Greg
Lee, Alina
Yuningsih, Yuni
Nielsen, C.
Bukh, P.
author_facet White, Greg
Lee, Alina
Yuningsih, Yuni
Nielsen, C.
Bukh, P.
author_sort White, Greg
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T06:07:31Z
format Journal Article
id curtin-20.500.11937-5518
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:07:31Z
publishDate 2010
publisher Emerald
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-55182017-09-13T14:42:51Z The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies White, Greg Lee, Alina Yuningsih, Yuni Nielsen, C. Bukh, P. 2010 Journal Article http://hdl.handle.net/20.500.11937/5518 10.1108/14691931011085669 Emerald restricted
spellingShingle White, Greg
Lee, Alina
Yuningsih, Yuni
Nielsen, C.
Bukh, P.
The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title_full The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title_fullStr The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title_full_unstemmed The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title_short The nature and extent of voluntary intellectual capital disclosures by Australian and UK biotechnology companies
title_sort nature and extent of voluntary intellectual capital disclosures by australian and uk biotechnology companies
url http://hdl.handle.net/20.500.11937/5518